Orange County Business Journal reported that Epinal Inc., an organization based in Irvine, has completed more than six years of development on a specialized technology. The specific technology is a semiconductor-based biosensor. According to the available facts, this semiconductor-based biosensor designed by Epinal Inc. has a distinct capability: it detects narcotics from human breath.
The history of the project spans a significant duration. Epinal Inc. has dedicated more than six years of development specifically to this semiconductor-based biosensor. Throughout the more than six years of development, Irvine-based Epinal Inc. has refined the semiconductor-based biosensor so that it successfully detects narcotics from human breath.
Looking toward the future timeline of the project, Epinal Inc. has established a firm production goal. Epinal Inc. targets the year 2028 to begin production of the semiconductor-based biosensor. The target to begin production in the year 2028 follows directly from the more than six years of development carried out by Irvine-based Epinal Inc. on the semiconductor-based biosensor that detects narcotics from human breath.
The human element behind the creation of the semiconductor-based biosensor by Epinal Inc. was addressed by Mark Wong. Mark Wong shared perspective on the broader impacts of narcotics and diseases. Mark Wong told Orange County Business Journal, "People around the world lose loved ones every day to narcotics and various diseases, myself included."
Mark Wong also elaborated on the potential health outcomes tied to the technology developed by Irvine-based Epinal Inc. Mark Wong told Orange County Business Journal, "We feel that with proactive screening and monitoring, countless lives can be saved with early detection and treatment."
The overarching mission of Epinal Inc., which is an enterprise based in Irvine, remains firmly tied to these public health considerations as the organization approaches its future operational milestones. Having already invested more than six years of development into the project, the semiconductor-based biosensor engineered to detect narcotics from human breath stands as the core innovation for Epinal Inc. As the firm looks ahead toward the coming years, Epinal Inc. targets the year 2028 to begin production, thereby establishing the official timeline for the semiconductor-based biosensor that has been crafted through more than six years of development by Irvine-based Epinal Inc.
